Search
programmed cell death protein 1; PDL1 receptor; protein PD-1; CD273 receptor; CD274 receptor; hPD-1 (PDCD1, hPD-1, CD279)
Function:
- possible cell death inducer in association with ligands CD273 & CD274 (PD-L1)
- inhibitory receptor expressed by T-cells
- a checkpoint inhibitor
Structure:
- contains 1 Ig-like V-type domain
Compartment:
- membrane; single-pass type 1 membrane protein
Expression:
- expressed by T-cells
- induced at programmed cell death
Pathology:
- genetic variation in PDCD1 is associated with susceptibility to systemic lupus erythematosus type 2
- expression on HIV1-specific T-cells is associated with T-cell exhaustion & disease progression [2]
Pharmacology:
- anti-PDCD1 antibody benefits 18-27% of patients with non-small-cell lung cancer, cutaneous melanoma or renal cell carcinoma [3]
- pembrolizumab (Keytruda) & nivolumab (Opdivo) block ligand activation of the PD-1 receptor on activated T cells
- PDCD1 is an inhibitory receptor expressed on activated tumor-specific CD4+ helper T-cells & CD8+ cytotoxic T-cells
- its major ligand PD-L1 is expressed in many human cancers [3]
Interactions
molecular events
Related
apoptosis
programmed cell death protein
General
cluster-of-differentiation antigen; cluster designation antigen; CD antigen
glycoprotein
membrane protein
receptor
Properties
SIZE: MW = 32 kD
entity length = 288 aa
COMPARTMENT: cellular membrane
MOTIF: signal sequence {1-20}
immunoglobulin superfamily domain {35-145}
MOTIF: N-glycosylation site {N49}
cysteine residue {C54}
MODIFICATION: cysteine residue {C123}
N-glycosylation site {N58}
N-glycosylation site {N74}
N-glycosylation site {N116}
cysteine residue {C123}
MODIFICATION: cysteine residue {C54}
transmembrane domain {171-191}
Database Correlations
OMIM correlations
UniProt Q15116
Pfam PF07686
Entrez Gene 5133
Kegg hsa:5133
References
- UniProt :accession Q15116
- Day CL et al,
PD-1 expression on HIV-specific T cells is associated with
T-cell exhaustion and disease progression.
Nature 2006, 443:350
PMID: 16921384
- Topalian SL et al
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody
in Cancer
N Engl J Med, June 2, 2012
PMID: 22658127
http://www.nejm.org/doi/full/10.1056/NEJMoa1200690